ARCHIVES

Two Studies Demonstrate Molecule Blocking Cell Damage

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Committee Approves NDA for Mitxantrone

March 21, 1986

NIH scientists defend industry ties while officials vow conflicts review; three investigations planned.

January 23, 2004

Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis

November 28, 2014

Biomarker May Predict Prostate Cancer Metastases

December 27, 2013

Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.

July 28, 2006

FDA Official Outlines agency’s Views On Efficacy Requirement

June 16, 1999